Patients for total hip arthroplasty
Conditions
Interventions
Postoperative lumbar plexus block with 20 ml of 0.15% levobupivacaine in patients undergoing hip replacement surgery.
No postoperative lumbar plexus block in patients undergoing hip replacement surger
Sponsors
Itabashi Chuo Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA-PS 1 or 2
Exclusion criteria
Exclusion criteria: ASA-PS 3 or higher, not a single operation (e.g. bilateral THA), unobserved withdrawal of antiplatelet/anticoagulant medication, patients with hepatic or renal dysfunction, patients with dementia, patients with allergy to local anesthetics, preoperative opioid use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain at rest and during movement will be assessed by NRS and compared at 30 minutes, 2 hours, 5 hours, 11 hours, the morning of the first postoperative day, and the morning of the second postoperative day after returning to the ward. | — |
Secondary
| Measure | Time frame |
|---|---|
| Presence or absence of motor paralysis and PONV at 30 minutes, 2 hours, 5 hours, 11 hours after returning to the ward, on the morning of the first postoperative day, and on the morning of the second postoperative day, number of times of antiemetic use,number of times rescue was used and time to first use, and patient satisfaction with pain | — |
Countries
Japan
Contacts
Public ContactYugo Ono
Itabashi Chuo Medical Center Department of Anesthesiology
Outcome results
None listed